Prevalence of Unrecognized Cognitive Impairment in Federally Qualified Health Centers
This cross-sectional study found that unrecognized cognitive impairment is ubiquitous among older adults from underrepresented, minoritized racial and ethnic groups and those who are socially vulnerable receiving primary care from FQHCs. To overcome the disparity in early detection of cognitive impairment, timely, equitable, scalable, and sustainable detection approaches need to be developed.
Authors
- Arthur H. Owora (ORCID: https://orcid.org/0000-0002-4580-7428)
- Nicole R. Fowler (ORCID: https://orcid.org/0000-0002-6465-0008)
- Malaz Boustani (ORCID: https://orcid.org/0000-0003-0330-677X)
- Diana Summanwar
- Ambar Kulshreshtha (ORCID: https://orcid.org/0000-0003-4610-1352)
- Erik Parker (ORCID: https://orcid.org/0000-0002-5537-7900)
- Zina Ben Miled (ORCID: https://orcid.org/0000-0001-5401-0368)
- James E. Galvin (ORCID: https://orcid.org/0000-0001-5678-245X)
Institutions
- Regenstrief Institute (US)
- University of Miami (US)
- Emory University (US)
- Indiana University Bloomington (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-10-22
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.40411
- Citations
- 21
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 8.10
Funders
- Eli Lilly and Company
- Biogen
- Eisai
- National Institutes of Health
- Genentech